Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions

Data ReadoutpositivecfDNA Fetal Risk AssessmentPositive

AI Analysis

Summary

BillionToOne reported results from a prospective study of over 2,200 pregnant carriers demonstrating strong clinical performance of cfDNA fetal risk assessment for screening recessive conditions in general-risk populations, with outcomes available for 98% of eligible results.

Clinical Trial Data

Primary Endpoint

Met

Patients

2,200

Outcome Details

Study of more than 2,200 pregnant carriers demonstrates strong clinical performance in general-risk population with outcomes available for more than 98% of eligible cfDNA results

Importance:6/10

Sentiment:

0.75

prospective studyprenatal screeningcell-free DNArecessive conditionsgeneral-risk populationcarrier screening

Related Companies

$BLLN

Read the original article

Published by PR Newswire Biotech on August 18, 2026 4:08 PM

Read Original